Misonix to Present at the 39th Annual Canaccord Genuity Growth Conference on August 8
July 18 2019 - 10:30AM
Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a
provider of minimally invasive therapeutic ultrasonic medical
devices that enhance clinical outcomes, today announced that it
will be participating in the Canaccord Genuity 39th Annual Growth
Conference held at the InterContinental Hotel in Boston,
Massachusetts on Thursday, August 8, 2019. Misonix President and
Chief Executive Officer, Stavros Vizirgianakis, will be making a
company presentation in the Vancouver Room at 11:00 a.m. ET that
day. Management will also be available to meet with institutional
investors in one-on-one meetings through-out the day.
The Misonix investor presentation is available
in the “Investor Relations” section of the Company’s website at
www.misonix.com. If you have questions about Misonix or are
interested in conducting a conference call or meeting with
management, please contact the Company’s investor relations firm,
JCIR, at (212) 835-8500 or via email at mson@jcir.com.
About Misonix, Inc.Misonix,
Inc. (NASDAQ: MSON) designs, manufactures and markets ultrasonic
medical devices for the precise removal of hard and soft tissue,
including bone removal, wound debridement and ultrasonic
aspiration. Misonix is focused on leveraging its proprietary
ultrasonic technology to become the standard of care in operating
rooms and clinics around the world. Misonix's proprietary
ultrasonic medical devices are used in a growing number of medical
procedures, including spine surgery, neurosurgery, orthopedic
surgery, cosmetic surgery, laparoscopic surgery, and other surgical
and medical applications. At Misonix, Better Matters to us. That is
why throughout the Company’s history, Misonix has maintained its
commitment to medical technology innovation and the development of
ultrasonic surgical products that radically improve patient
outcomes. Additional information is available on the Company's web
site at www.misonix.com.
Contact: Joe Dwyer
Chief Financial Officer Misonix,
Inc.
631-927-9113
Norberto Aja, Jennifer NeumanJCIR212-835-8500 or
mson@jcir.com
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Mar 2024 to Apr 2024
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Apr 2023 to Apr 2024